Six SADC countries have now removed VAT from menstrual products, and eight countries provide menstrual hygiene products in schools, mainly in rural and disadvantaged communities.
Regional progress on reproductive health shows that eight SADC countries have successfully met or surpassed their family planning targets, while six member states have yet to achieve these benchmarks.
Access to basic sanitation and handwashing facilities remains low in all countries except Mauritius and Seychelles.
The regional average of unmet need for contraception in southern Africa remains high at approximately 19%, which exceeds the global average of 9%.
The lowest unmet need is in Mauritius, at about 10%, while Angola has the highest rate, estimated at 38% of married women. This rate reflects significant challenges in family planning and gender equality in Angola, where the modern contraceptive prevalence rate remains one of the lowest in the region at just 12.5%.
Maternal mortality remains stubbornly high. Only Mauritius and Seychelles have met the SDG target of fewer than 70 deaths per 100,000 live births.
The DRC has the highest maternal mortality rate, with 693 deaths per 100,000 live births.
Efforts to lower maternal mortality across SADC have seen varied progress, with high rates in several other nations, including Malawi and Zimbabwe, where economic instability and healthcare limitations are contributing factors. Reducing maternal mortality remains a critical priority, especially given the need for consistent healthcare access and quality maternal services across the region.
Nine countries in SADC have included Human Papillomavirus (HPV) in their national vaccination programme, though coverage varies across countries, from 98% in Seychelles to 55% in Botswana.
The prevalence rate of cervical cancer per 100,000 women per year attributable to HPV is higher than the Africa average of 26 incidences in all countries except Mauritius.
Ten SADC countries now have national cervical cancer screening programmes. However, large-scale coverage remains a challenge, ranging from 4% in Mozambique to 56% in South Africa for women ever being screened for cervical cancer.
We use cookies to enhance your browsing experience, serve personalised content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.
Customise Consent Preferences
This site uses cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies categorised as Necessary are stored on your browser as they are essential for enabling the basic functionalities of the site. We also use analytics cookies to understand how you use this website; you can switch these off below at any time. Marketing cookies are only stored in your browser with your prior consent.
Always Active
Essential for the website to function. These cannot be disabled and do not store any personally identifiable data.
Cookie
Duration
Description
CRAFT_CSRF_TOKEN
Session
Protects against cross-site request forgery attacks.
PHPSESSID
Session
Preserves your session state across page requests.
flow_cookie_consent
1 year
Remembers your cookie consent preferences.
Help us understand how visitors use the site by collecting anonymised metrics — visitor count, bounce rate, and traffic source. You can switch these off here at any time.
Cookie
Duration
Description
_ga
1 year 1 month
Google Analytics sets this to store and count page views.
_ga_*
1 year 1 month
Google Analytics uses this to persist session state.
_gid
24 hours
Stores and updates a unique value for each page visited.
Used for targeted advertising. Only stored with your consent.